EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

The Chronic Lymphocytic Leukemia Epigenome

Antonio Perez-Castro, Lynne V Abruzzo, Christopher C Oakes

Hematology/Oncology Clinics of North America · 2025

DOI: 10.1016/j.hoc.2025.05.005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Hematology/Oncology Clinics of North America, 2025. Verfasst von Antonio Perez-Castro und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Ohio State University Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, …. Hauptthemen laut MEDLINE: Leukemia, Lymphocytic, Chronic, B-Cell, Epigenesis, Genetic, DNA Methylation, Epigenome. Die Arbeit nennt 99 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, American Cancer Society, National Institutes of Health National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review explores how epigenetic information, and in particular DNA methylation-based "epitypes," enhances our understanding of chronic lymphocytic leukemia (CLL) biology and prognosis. Epitypes correlate with B-cell maturation stages and outperform traditional biomarkers like immunoglobulin heavy chain variable region mutation status in predicting outcomes. The stability and specificity of CLL epigenetic patterns offer insights into disease history, risk stratification, and treatment response, even amid evolving therapeutic landscape. Emerging epigenetic signatures, including proliferative indices, further refine patient classification and outcome prediction, underscoring the potential clinical utility of integrating epigenetic data in CLL management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Lymphocytic, Chronic, B-CellEpigenesis, GeneticDNA MethylationEpigenomeGene Expression Regulation, LeukemicHumansPrognosisBiomarkers, TumorMutation

Stichwörter der Autor:innen

B cell receptor (BCR)BiomarkersChronic lymphocytic leukemia (CLL)DNA methylationEpigeneticsGerminal center (GC)Immunoglobulin heavy chain variable region genes

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • The Ohio State University Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH, USA.
  • Pathology and Laboratory Medicine, Department of Pathology and Laboratory Medicine, The Medical University of South Carolina, Charleston, SC 29425-9080, USA.
  • The Ohio State University Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH, USA; Division of Hematology, Department of Internal Medicine, The…

Förderung

  • NCI NIH HHS
  • American Cancer Society
  • National Institutes of Health National Cancer Institute
  • National Institutes of Health

Zitieren

APA

Perez-Castro, A., Abruzzo, L. V., & Oakes, C. C. (2025). The Chronic Lymphocytic Leukemia Epigenome. Hematology/Oncology Clinics of North America. https://doi.org/10.1016/j.hoc.2025.05.005

Vancouver

Perez-Castro A, Abruzzo LV, Oakes CC. The Chronic Lymphocytic Leukemia Epigenome. Hematology/Oncology Clinics of North America. 2025. doi:10.1016/j.hoc.2025.05.005

BibTeX
@article{PerezCastro2025,
  author = {Perez-Castro, Antonio and Abruzzo, Lynne V and Oakes, Christopher C},
  title = {The Chronic Lymphocytic Leukemia Epigenome},
  journal = {Hematology/Oncology Clinics of North America},
  year = {2025},
  doi = {10.1016/j.hoc.2025.05.005}
}
Kostenlos starten →